Donna M. Williams

发表

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

Henryk Mach, Norman L. Letvin, Michelle A. Lifton, 2002, Nature.

Immune response and reactogenicity of an unadjuvanted intradermally delivered human papillomavirus vaccine using a first generation Nanopatch™ in rhesus macaques: An exploratory, pre-clinical feasibility assessment

R. K. Evans, M. Kendall, D. Casimiro, 2019, Vaccine: X.

Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders.

C. Dang, P. Mali, Linzhao Cheng, 2009, Blood.

between quantitative JAK2 V617F and Mpl expression Molecular mimicry in the chronic myeloproliferative disorders: reciprocity

J. Spivak, A. Moliterno, Donna M. Williams, 2013 .

donors and patients with acquired blood disorders Human-induced pluripotent stem cells from blood cells of healthy

P. Mali, Ye Lin, J. Spivak, 2009 .

Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosis.

J. Spivak, A. Moliterno, Donna M. Williams, 2007, Experimental hematology.

Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expression.

J. Spivak, A. Moliterno, Donna M. Williams, 2006, Blood.

Thrombopoietin is required for full phenotype expression in a JAK2V617F transgenic mouse model of polycythemia vera

Wanke Zhao, Z. Zhao, L. Resar, 2020, PloS one.

Mpl Baltimore: a thrombopoietin receptor polymorphism associated with thrombocytosis.

J. Spivak, R. Ingersoll, A. Moliterno, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden.

S. Karanika, T. Karantanos, L. Resar, 2020, Blood advances.

Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes

M. McDevitt, C. O'keefe, A. Verma, 2011, Haematologica.

Disease burden at the progenitor level is a feature of primary myelofibrosis: a multivariable analysis of 164 JAK2 V617F-positive myeloproliferative neoplasm patients.

J. Spivak, M. Isaacs, A. Moliterno, 2011, Experimental hematology.

Phenotypic variability within the JAK2 V617F-positive MPD: roles of progenitor cell and neutrophil allele burdens.

J. Spivak, M. Isaacs, A. Moliterno, 2008, Experimental hematology.

Binding of HMG‐I(Y) elicits structural changes in a silencer of the human β‐globin gene

J. Strovel, Z. Bi, S. Haga, 1999, American journal of hematology.

Sex differences in the JAK2V617F allele burden in chronic myeloproliferative disorders

N. Pemmaraju, Nae-Yuh Wang, J. Spivak, 2010, Haematologica.

A Functional Thrombopoietin Receptor Is Required for Full Expression of Phenotype in a JAK2 V617F Transgenic Mouse Model of Polycythemia Vera

Z. Zhao, A. Merchant, J. Spivak, 2012 .

Impaired Expression of the Thrombopoietin Receptor, Mpl, in Polycythemia Vera

J. Spivak, A. Moliterno, Donna M. Williams, 2004 .

The Expression and Role of Human Erythropoietin Receptor in Erythroid and Nonerythroid Cells

A. Schechter, T. Zimmers, J. Pierce, 1994, Annals of the New York Academy of Sciences.

Development of stable liquid formulations for adenovirus-based vaccines.

R. K. Evans, J. Shiver, D. Volkin, 2004, Journal of pharmaceutical sciences.

A common protein binds to two silencers 5′ to the human β-globin gene

A. Schechter, R. Cohen, R. Qian, 1989 .

The indoleamine 2,3 dioxygenase pathway drives intratumoral B cell maintenance

S. Desiderio, D. McConkey, L. Xian, 2021, bioRxiv.

Flow Cytometry in the Preclinical Development of Biopharmaceuticals

D. Williams, Donna M. Williams, K. Gossett, 1999, Toxicologic pathology.

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

R. K. Evans, T. Toner, J. Shiver, 2003, Journal of Virology.

Two clinical phenotypes in polycythemia vera.

M. Ochs, J. Spivak, M. Considine, 2014, The New England journal of medicine.

Characterization of myeloproliferative neoplasms in the paediatric and young adult population

T. Karantanos, L. Resar, Shruti Chaturvedi, 2023, British journal of haematology.

HMGA1 Chromatin Regulators Induce Transcriptional Networks Involved in GATA2 and Proliferation During MPN Progression.

R. Koche, Z. Zhao, L. Xian, 2022, Blood.

Heterogeneous JAK2V617F Allele Burden in Essential Thrombocytosis: Gender and Clinical Correlates.

N. Pemmaraju, J. Spivak, A. Moliterno, 2006 .

Germline ERBB2/HER2 Coding Variants Are Associated with Increased Risk of Myeloproliferative Neoplasms

N. Sobreira, T. Karantanos, Elizabeth S Wohler, 2021, Cancers.

BP1, a new homeobox gene, is frequently expressed in acute leukemias

F. Behm, S. Raimondi, B. Smith, 2000, Leukemia.

Disruption of the ASXL1 Gene Is Prevalent In PMF: Analysis of Molecular Genetics and Clinical Phenotypes

M. McDevitt, C. O'keefe, J. Maciejewski, 2010 .

Characterization and biological evaluation of a microparticle adjuvant formulation for plasmid DNA vaccines.

R. K. Evans, J. Shiver, D. Volkin, 2004, Journal of pharmaceutical sciences.

Cloning restriction fragments that promote expression of a gene in Bacillus subtilis

D. Williams, E. Duvall, P. S. Lovett, 1981, Journal of bacteriology.

JAK2V671F, Gender and the Gene Expression Profile of Polycythemia Vera

A. Moliterno, Donna M. Williams, C. Jie, 2008 .

The quantitative JAK2 V617F neutrophil allele burden does not correlate with thrombotic risk in essential thrombocytosis

N. Pemmaraju, J. Spivak, D. Williams, 2007, Leukemia.